Not exact matches
«Proper blood
cell production is dependent on functioning
hematopoietic stem and progenitor
cells that are destroyed during conditioning procedures for transplantation or following
bone marrow injury,» said the study's first author Kevin A. Goncalves, who performed this research as part of his PhD studies
in cellular and molecular physiology at the Sackler School.
In addition to suppressing the mature blood cells battling against the infection, malfunctioning of this signaling system results in permanent damage to the body's blood producing cells — called hematopoietic stem cells — that are located in the bone marro
In addition to suppressing the mature blood
cells battling against the infection, malfunctioning of this signaling system results
in permanent damage to the body's blood producing cells — called hematopoietic stem cells — that are located in the bone marro
in permanent damage to the body's blood producing
cells — called
hematopoietic stem
cells — that are located
in the bone marro
in the
bone marrow.
Hematopoietic stem
cells —
bone marrow - derived adult stem
cells that give rise to the wide variety of specialized blood
cells — come
in two flavors: the reserve force sits quietly waiting to be called upon while the active arm continually proliferates spawning billions of blood
cells every day.
To gauge the effect off the loss of imprinting control on the maintenance of the quiescent
hematopoietic stem
cell pool, Venkatraman analyzed the numbers of quiescent, active and differentiated
hematopoietic stem
cells in mouse
bone marrow.
Our blood is generated by blood - forming (
hematopoietic) stem
cells (HSCs)
in the
bone marrow.
These so - called
hematopoietic stem
cells (from Greek meaning «to make blood») have been reliably used over the past 40 years to seed
bone marrow transplants
in the treatment of some cancers and immune disorders.
In fact, hematopoietic stem cells differentiate to generate megakaryocytes in bone marro
In fact,
hematopoietic stem
cells differentiate to generate megakaryocytes
in bone marro
in bone marrow.
Employing the advanced technology of the Institute's Cytometry, Imaging and Histology centers, the researchers examined the relationship between megakaryocytes and
hematopoietic stem
cells in mouse
bone marrow.
In the study, USC Stem Cell researcher Casey Brewer and colleagues in the laboratory of Rong Lu found that transplantation dose affects the behavior of blood - forming stem cells in bone marrow — called hematopoietic stem cells, or HSC
In the study, USC Stem
Cell researcher Casey Brewer and colleagues
in the laboratory of Rong Lu found that transplantation dose affects the behavior of blood - forming stem cells in bone marrow — called hematopoietic stem cells, or HSC
in the laboratory of Rong Lu found that transplantation dose affects the behavior of blood - forming stem
cells in bone marrow — called hematopoietic stem cells, or HSC
in bone marrow — called
hematopoietic stem
cells, or HSCs.
«We found that TRAF6 overexpression
in mouse
hematopoietic stem
cells results
in impaired blood
cell formation and
bone marrow failure,» said Starczynowski, a member of the Division of Experimental Hematology and Cancer Biology at Cincinnati Children's Hospital Medical Center.
Leukemia starts
in the «
hematopoietic» stem
cells in the
bone marrow that give rise to all the different kinds of mature blood
cells.
Beilhack and colleagues found that a slightly modified version of STAR2 has a similar effect on human T reg
cells, suggesting that the approach could also prevent GvHD
in leukemia and lymphoma patients after
bone marrow or
hematopoietic stem
cell transplants.
Tie2 / angiopoietin -1 signaling regulates
hematopoietic stem
cell quiescence
in the
bone marrow niche.
Furthermore, these potentials are expanded by the notion that MSCs can exert functions other than those classically attributed to stem or progenitor
cells, including establishment and support of the
hematopoietic microenvironment
in vivo, as observed for
bone marrow derived MSCs.
Human immunodeficiency virus (HIV) can infect
bone marrow cells — including, possibly,
hematopoietic stem
cells, according to a study published online today (March 7)
in Nature Medicine.
Cytokinesis failure occurs
in Fanconi anemia pathway — deficient murine and human
bone marrow hematopoietic cells.
Furthermore, stem
cells in bone marrow may form not just
hematopoietic cells, but cardiac muscle
cells, neural
cells, and other types of
cells; this is an example of stem -
cell plasticity.
This new knowledge has paved the way for the therapeutic transfer of stem
cells not only for the treatment of
hematopoietic diseases by
bone marrow transplantation â $» first attempted by E. Donnall Thomas, one of this bookâ $ ™ s editors,
in 1957 â $» but also for the treatment of many other disorders.
Bone marrow CD169 + macrophages promote the retention of
hematopoietic stem and progenitor
cells in the mesenchymal stem
cell niche.
Platelets (or thrombocytes) control the process of blood clotting and transfusions are common to prevent bleeding
in treatments involving
hematopoietic stem
cell (HSC) and
bone marrow (BM) transplantation [1].
The chemotherapy is designed to make space
in the
bone marrow for the gene - corrected
hematopoietic stem
cells to settle
in and start working.
The
Hematopoietic stem
cell population resident
in bone marrow is responsible for generating blood
cells and immune
cells.
Added to this is the fact that white fat also damages the
hematopoietic stem
cells of
bone marrow which could results
in reduced blood
cell formation
in bone with excess fatty infiltration.
In her project, Sipkins will investigate molecular characteristics of tissue microenvironments, or «niches,» within the
bone marrow and how normal, healthy
hematopoietic stem
cells, which give rise to the many kinds of blood
cells, compete with malignant
cells to occupy these coveted niches.
A quantitative assessment of the content of
hematopoietic stem
cells in mouse and human endosteal -
bone marrow: a simple and rapid method for the isolation of mouse central
bone marrow.
For example, we have no information about how these newly - generated HPCs will compete with autologous
bone marrow cells for
hematopoietic niches
in the recipient mice.
We also analyzed the
hematopoietic stem
cells and various progenitor
cells in the
bone marrow.
Myelosuppression is a well - established side effect of current AML therapies, with prolonged events leading to an increased risk of infections and death.44 Consequently, therapies that preferentially kill leukemic
cells over normal
bone marrow cells are urgently required, and the overexpression of CD123 on AML leukemic stem
cells and blasts compared with normal
hematopoietic cells contributes to its attractiveness as a therapeutic target
in this disease.6, 45 However, severe myelosuppression and myeloablation have emerged for some investigational CD123 - targeted treatment modalities.
Red
marrow in the long
bones is the pool from which
hematopoietic stem
cells originate.